These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 18290640)

  • 1. New combined model for the prediction of regioselectivity in cytochrome P450/3A4 mediated metabolism.
    Oh WS; Kim DN; Jung J; Cho KH; No KT
    J Chem Inf Model; 2008 Mar; 48(3):591-601. PubMed ID: 18290640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EaMEAD: Activation energy prediction of cytochrome P450 mediated metabolism with effective atomic descriptors.
    Kim DN; Cho KH; Oh WS; Lee CJ; Lee SK; Jung J; No KT
    J Chem Inf Model; 2009 Jul; 49(7):1643-54. PubMed ID: 19545128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Mechanism-Based Model for the Prediction of the Metabolic Sites of Steroids Mediated by Cytochrome P450 3A4.
    Dai ZR; Ai CZ; Ge GB; He YQ; Wu JJ; Wang JY; Man HZ; Jia Y; Yang L
    Int J Mol Sci; 2015 Jun; 16(7):14677-94. PubMed ID: 26133240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of Metabolism Prediction Models for CYP450 3A4, 2D6, and 2C9 Based on Microsomal Metabolic Reaction System.
    He SB; Li MM; Zhang BX; Ye XT; Du RF; Wang Y; Qiao YJ
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27735849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RS-predictor: a new tool for predicting sites of cytochrome P450-mediated metabolism applied to CYP 3A4.
    Zaretzki J; Bergeron C; Rydberg P; Huang TW; Bennett KP; Breneman CM
    J Chem Inf Model; 2011 Jul; 51(7):1667-89. PubMed ID: 21528931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidating substrate promiscuity in the human cytochrome 3A4.
    Hayes C; Ansbro D; Kontoyianni M
    J Chem Inf Model; 2014 Mar; 54(3):857-69. PubMed ID: 24571781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using chemical bond-based method to predict site of metabolism for five biotransformations mediated by CYP 3A4, 2D6, and 2C9.
    Fu X; He S; Du L; Lv Z; Zhang Y; Zhang Q; Wang Y
    Biochem Pharmacol; 2018 Jun; 152():302-314. PubMed ID: 29588194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel approach to predicting P450 mediated drug metabolism. CYP2D6 catalyzed N-dealkylation reactions and qualitative metabolite predictions using a combined protein and pharmacophore model for CYP2D6.
    de Groot MJ; Ackland MJ; Horne VA; Alex AA; Jones BC
    J Med Chem; 1999 Oct; 42(20):4062-70. PubMed ID: 10514276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of reacting atoms for the major biotransformation reactions of organic xenobiotics.
    Rudik AV; Dmitriev AV; Lagunin AA; Filimonov DA; Poroikov VV
    J Cheminform; 2016; 8():68. PubMed ID: 27994650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fast prediction of cytochrome P450 mediated drug metabolism.
    Rydberg P; Vasanthanathan P; Oostenbrink C; Olsen L
    ChemMedChem; 2009 Dec; 4(12):2070-9. PubMed ID: 19852016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Approaches for Investigating and Predicting Cytochrome P450 3A4-Ligand Interactions.
    Sevrioukova IF; Poulos TL
    Adv Exp Med Biol; 2015; 851():83-105. PubMed ID: 26002732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of small-molecule binding to cytochrome P450 3A4: flexible docking combined with multidimensional QSAR.
    Lill MA; Dobler M; Vedani A
    ChemMedChem; 2006 Jan; 1(1):73-81. PubMed ID: 16892339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting drug-drug interactions by electrochemically driven cytochrome P450 3A4 reactions.
    Shumyantseva VV; Koroleva PI; Bulko TV; Sergeev GV; Usanov SA
    Drug Metab Pers Ther; 2022 Sep; 37(3):241-248. PubMed ID: 34860476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple substrate binding by cytochrome P450 3A4: estimation of the number of bound substrate molecules.
    Kapelyukh Y; Paine MJ; Maréchal JD; Sutcliffe MJ; Wolf CR; Roberts GC
    Drug Metab Dispos; 2008 Oct; 36(10):2136-44. PubMed ID: 18645035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of methods for the prediction of the metabolic sites for CYP3A4-mediated metabolic reactions.
    Zhou D; Afzelius L; Grimm SW; Andersson TB; Zauhar RJ; Zamora I
    Drug Metab Dispos; 2006 Jun; 34(6):976-83. PubMed ID: 16540587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of the affinity and metabolism of type I and type II binding quinoline carboxamide analogues by cytochrome P450 3A4.
    Dahal UP; Joswig-Jones C; Jones JP
    J Med Chem; 2012 Jan; 55(1):280-90. PubMed ID: 22087535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting drug metabolism by cytochrome P450 2C9: comparison with the 2D6 and 3A4 isoforms.
    Rydberg P; Olsen L
    ChemMedChem; 2012 Jul; 7(7):1202-9. PubMed ID: 22593031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative Prediction of Regioselectivity Toward Cytochrome P450/3A4 Using Machine Learning Approaches.
    Hasegawa K; Koyama M; Funatsu K
    Mol Inform; 2010 Mar; 29(3):243-9. PubMed ID: 27462767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of Sites of Metabolism of CYP3A4 Substrates Utilizing Docking-Derived Geometric Features.
    Feng Y; Gong C; Zhu J; Liu G; Tang Y; Li W
    J Chem Inf Model; 2023 Jul; 63(13):4158-4169. PubMed ID: 37336765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration of enzyme-ligand interactions in CYP2D6 & 3A4 homology models and crystal structures using a novel computational approach.
    Kjellander B; Masimirembwa CM; Zamora I
    J Chem Inf Model; 2007; 47(3):1234-47. PubMed ID: 17381082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.